Popular Articles
Revitol Cellulite Cream

Training Program To Prevent Groundwater Poisoning In India
A team of scientists at Queen"s University has been chosen to lead a top research and training programme to prevent groundwater poisoning in India. Don't forget to buy zoloft online no prescription.

Covidien Announces Health Canada Approval For Its Generic Myocardial Perfusion Imaging Kit
Covidien (NYSE: COV), a leading global provider of healthcare products, announced that Health Canada has approved the Company"s Abbreviated New Drug Submission (ANDS) for its Kit for the Preparation of Technetium Tc 99m Sestamibi Injection. Covidien"s generic product is fully substitutable for Cardiolite®, a myocardial perfusion imaging agent used for detecting coronary artery disease.

generic viagra online


News of the day
Boston Launches Safer-Sex Campaign Targeting Teenagers Using Social Networking Sites, Other Outlets
The Boston Public Health Commission has allocated $100,000 to a new campaign that uses social networking sites and other media outlets to raise sexual health awareness among teenagers, the Boston Globe reports. The city is facing increasing rates of sexually transmitted diseases among those age 15 to 19, according to the Globe. The new campaign will include educational videos featuring teenagers that will air on the MTV, FX and BET television networks; radio and mass transit advertisements; and theater performances. Facebook, YouTube and other social networking sites also will be used to reach teenagers with safer sex messages. Officials hope to address teenagers" "casual attitudes" toward sexually transmitted diseases, the Globe reports. Lydia Shrier, an adolescent medicine specialist at Children"s Hospital Boston, said teenagers might say ""Hey, I may get HIV, but it"s treatable and I"m going to live." It"s not a death sentence to them" (Smith, 8/4).
Endocrinology

Scripps Discovers Genetic Clues Into Formation Of Cancer Tumors

A new research study from Scripps Health provides previously unknown genetic clues into how cancerous tumors are formed in the human breast, brain and colorectal system. The findings by researchers at Scripps Translational Science Institute (STSI) will be published in the September 2009 edition of the journal Genome Research. STSI researchers analyzed genetic data from 44 breast cancer, colorectal cancer and glioblastoma tumors and identified specific mutations within groups of genes that are strongly involved in tumor formation. A mutation is a change in a cell"s DNA. While a large number of mutations occur within any tumor, not all of them contribute directly to the tumor"s growth. Some mutations are akin to "random noise" while other mutations cause a growth advantage for tumors. The STSI study differentiated between the random and causative mutations. "Understanding which specific mutations cause a tumor to form is an important step that may potentially translate into a more personalized approach to treating cancer patients," said Ali Torkamani, Ph.D., an STSI research scientist and the study"s principal investigator. "These mutations provide us with targets for drug development that presumably would be more efficient at killing cancer, with lower toxicity levels that are safer for patients." The new study builds upon earlier research conducted by Johns Hopkins University scientists, who sequenced cancerous tumors and studied individual genes linked to tumor growth. Because there are many different ways a tumor can be formed, STSI designed its research to look at groups of genes. Torkamani co-authored the study with Nicholas Schork, Ph.D., director of bioinformatics and biostatistics for STSI. Scripps Translational Science Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):